| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $69,003,625 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL158081 | Role of BRD4 in Normal Hematopoiesis and Hematopoietic Stem Cell Biology | 004 | 2 | NIH | 2/11/2023 | $31,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH125979 | Gene editing in the brain with CRISPR-PEG | 000 | 3 | NIH | 1/27/2023 | $608,458 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA249305 | The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC | 002 | 4 | NIH | 3/15/2023 | $28,316 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA224672 | Cognitive impairment associated with androgen deprivation therapy for prostate cancer | 000 | 5 | NIH | 11/29/2022 | $310,641 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R61AT012117 | Development of a phenotypic screening assay for novel compounds that inhibit peripheral pain-sensing neurons | 000 | 1 | NIH | 3/17/2023 | $437,991 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32DA057804 | Cannabinoid type 2 receptors as a therapeutic target for substance use disorders | 003 | 1 | NIH | 4/27/2023 | -$63,424 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA239227 | FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers | 003 | 4 | NIH | 3/15/2023 | $5,360 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01HL146382 | RURAL: Risk Underlying Rural Areas Longitudinal Cohort Study | 006 | 5 | NIH | 4/4/2023 | $49,995 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031716 | Glycolytic metabolites, Calcium entry and Sjogren?s syndrome | 000 | 2 | NIH | 6/2/2023 | $563,834 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM141631 | Repair of DNA ends with adducts | 000 | 1 | NIH | 3/13/2023 | $310,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI172207 | Translational Regulation of Candida glabrata Azole Resistance | 000 | 1 | NIH | 1/20/2023 | $193,750 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI166843 | The impact of aging and thymus regeneration on tissue-resident CD8 T cell responses to viral lung infection and vaccination | 000 | 2 | NIH | 5/11/2023 | $193,750 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA257391 | PAI-1-mediated early-onset endometrial cancer | 000 | 3 | NIH | 5/31/2023 | $437,953 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI153506 | IL-27-producing B cells in the antibody response | 000 | 3 | NIH | 1/12/2023 | $444,851 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA239227 | FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers | 002 | 4 | NIH | 3/15/2023 | $31,840 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA048417 | A novel opioid receptor antagonist for treating abuse and overdose | 000 | 5 | NIH | 2/1/2023 | $492,438 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA278370 | The Mechanistic Role of BRCA1-BARD1 DNA and RAD51 Binding in DNA Double-Strand Break Repair | 000 | 1 | NIH | 4/14/2023 | $37,656 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA278370 | The Mechanistic Role of BRCA1-BARD1 DNA and RAD51 Binding in DNA Double-Strand Break Repair | 001 | 1 | NIH | 4/14/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32DK134051 | Osteocytic Connexin 43 Hemichannel Regulation of Adiposity | 000 | 1 | NIH | 12/20/2022 | $70,282 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32DK134051 | Osteocytic Connexin 43 Hemichannel Regulation of Adiposity | 001 | 1 | NIH | 12/20/2022 | $0 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI161400 | Targeting SARS-CoV-2 induced lung immunopathology using novel genetic mouse models | 000 | 2 | NIH | 4/27/2023 | $190,161 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL157366 | The Impact of High Fat Diet on Brainstem Vagal Regulation | 001 | 2 | NIH | 4/1/2023 | $386,936 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL157366 | The Impact of High Fat Diet on Brainstem Vagal Regulation | 000 | 2 | NIH | 3/21/2023 | $434,025 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI148641 | Development of a rapid, pan fungal diagnostic assay | 000 | 3 | NIH | 1/9/2023 | $452,461 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG070214 | The role of CELF2 and its genetic variants in Alzheimer's disease | 000 | 3 | NIH | 1/26/2023 | $451,056 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32DA056212 | 14-3-3 gamma regulation of peripheral kappa opioid receptor function | 000 | 1 | NIH | 4/5/2023 | $70,926 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32DA056212 | 14-3-3 gamma regulation of peripheral kappa opioid receptor function | 001 | 1 | NIH | 4/5/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32DK134051 | Osteocytic Connexin 43 Hemichannel Regulation of Adiposity | 002 | 1 | NIH | 2/17/2023 | $1,918 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | K01NS126489 | Delineating the role of the gut microbiota and its derived metabolites in the development of dementia in multi-ethnic populations | 000 | 1 | NIH | 1/30/2023 | $220,446 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK128247 | The Regulation of Hepatic Metabolic Zonation by the Diabetes Gene TCF7L2 | 000 | 2 | NIH | 1/13/2023 | $489,396 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 001 | 2 | NIH | 2/14/2023 | $72,458 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM141091 | Genome Maintenance via the BRCA-RAD54 Axis | 000 | 3 | NIH | 2/10/2023 | $325,500 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM141091 | Genome Maintenance via the BRCA-RAD54 Axis | 001 | 3 | NIH | 2/13/2023 | $66,350 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM140456 | Mitochondrial 2-hydroxyglutarate dehydrogenases modulate the cellular epitranscriptome | 001 | 3 | NIH | 2/16/2023 | $31,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | K01AG066747 | Dysregulated intracellular calcium in microglia during Alzheimer's disease | 000 | 4 | NIH | 3/15/2023 | $113,454 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01ES031522 | Oxidative stress and RNA methylation | 000 | 4 | NIH | 1/27/2023 | $387,500 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25DK121576 | San Antonio Program for Undergraduate Research in Renal Science (SPURRS) | 000 | 5 | NIH | 1/9/2023 | $112,719 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD087417 | Molecular basis of MED12 in the pathogenesis of uterine fibroids | 004 | 7 | NIH | 5/19/2023 | $363,682 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA058018 | Gabapentinoid/opioid mixtures: abuse and toxicity | 000 | 1 | NIH | 3/31/2023 | $460,169 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UH3DA048387 | Methocinnamox (MCAM): A novel ????-opioid receptor antagonist for opioid use disorders | 000 | 2 | NIH | 1/26/2023 | $4,218,078 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | RF1NS076815 | Endocannabinoids in neurodegenerative diseases | 000 | 12 | NIH | 1/25/2023 | $2,151,868 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA262657 | Improving Therapeutic Approaches for RAS-driven Embryonal Rhabdomyosarcoma | 000 | 2 | NIH | 2/7/2023 | $347,471 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM145294 | Magnesium flux compendium: Discover ligands, channels, and metabolic signals | 001 | 2 | NIH | 5/29/2023 | $250,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 000 | 2 | NIH | 12/28/2022 | $652,130 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31AI169993 | Molecular and cellular properties of broad and protective immune responses to the Plasmodium falciparum variant surface antigen responsible for severe malaria | 000 | 2 | NIH | 4/25/2023 | $36,934 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00HL143277 | Protective effects of amlexanox against atherosclerosis | 000 | 5 | NIH | 5/1/2023 | $249,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA257148 | Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy | 001 | 3 | NIH | 3/8/2023 | $68,128 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM140456 | Mitochondrial 2-hydroxyglutarate dehydrogenases modulate the cellular epitranscriptome | 000 | 3 | NIH | 12/16/2022 | $279,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG062531 | Contributions of sleep to preclinical and clinical Alzheimer's disease | 000 | 4 | NIH | 1/31/2023 | $742,593 |
|
